Latest return on equity
Rigel Pharmaceuticals Return on equity
Direct answer
Rigel Pharmaceuticals's return on equity is 126.9%.
The verified market snapshot reports 126.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 126.9%
Explore related company data
View Rigel Pharmaceuticals's market capitalizationView Rigel Pharmaceuticals's p/e ratioView Rigel Pharmaceuticals's price-to-book ratioView Rigel Pharmaceuticals's dividend yieldView Rigel Pharmaceuticals's 52-week price rangeView Rigel Pharmaceuticals's revenue growthView Rigel Pharmaceuticals's profit marginView Rigel Pharmaceuticals's debt-to-equity ratioView all Rigel Pharmaceuticals key metricsReturn to Rigel Pharmaceuticals profile